Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of CIK in Combination With Temozolomide With and Without Radiation in Adults With Advanced Malignant Gliomas

NCT02496988 is registered in ClinicalTrials.gov with The First People's Hospital of Changzhou as lead sponsor.

NCT NCT02496988
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02496988 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of CIK in Combination With Temozolomide With and Without Radiation in Adults With Advanced Malignant Gliomas
Lead sponsor
The First People's Hospital of Changzhou
Phase
Phase 4
Overall status
Not yet recruiting
Start date
July 31, 2015
Completion date
July 31, 2030
Enrollment
120 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

advanced milignant gliomas, cytokine-induced killer cells